# Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer

> **NCT03921996** · PHASE3 · TERMINATED · sponsor: **Swiss Cancer Institute** · enrollment: 57 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** Radical prostatectomy (RP) followed by ePLND
- **PROCEDURE:** Radical prostatectomy (RP) only

## Key facts

- **NCT ID:** NCT03921996
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-27
- **Primary completion:** 2021-11-11
- **Final completion:** 2021-11-11
- **Target enrollment:** 57 (ACTUAL)
- **Why stopped:** Due to lack of funding.
- **Last updated:** 2023-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03921996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03921996, "Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03921996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*